´ëÇÑÆó°æÇÐȸ Á¦60Â÷ Ãß°èÇмú´ëȸ : 2023-11-19
±³À°ÀÏÀÚ : 2023-11-19
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ¼ºÀDZ³Á¤ ¿È´Ï¹ö½ºÆÄÅ© LÃþ(B3) Ç÷»Æ¼ÄÁº¥¼Ç
±³À°ÁÖÁ¦ : Á¦60Â÷ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÆó°æÇÐȸ
´ã´çÀÚ : ±èº¸¿µ
¿¬¶ôó : 010-7151-1633
À̸ÞÀÏ : ksm1992@empas.com
±³À°Á¾·ù : »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, °¡Á¤ÀÇÇаú, ¾à¸®ÇÐ, ÀÇÇб³À°, ±âŸ
Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 90,000¿ø
ºñ°í "ȸ¿ø : »çÀüµî·Ï 7¸¸¿ø , ÇöÀåµî·Ï 8¸¸¿ø
ºñȸ¿ø : »çÀüµî·Ï 8¸¸¿ø, ÇöÀåµî·Ï 9¸¸¿ø
Àü°øÀÇ,°£È£»ç : »çÀüµî·Ï 4¸¸¿ø, ÇöÀåµî·Ï 5¸¸¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:00~09:10 (±¸¿¬¹ßÇ¥)A study comparing efficacy of transdermal MHT and oral MHT on bone health in women with functional hypothalamic amenorrhea ±è°æ¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:10~09:20 (±¸¿¬¹ßÇ¥)Investigation for relationship between menopausal vasomotor symptoms and hypothalamus volumetry using magnetic resonance imaging among Korean women Á¤³ª¿µ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:20~09:30 (±¸¿¬¹ßÇ¥)Successful removal of an old pessary with the total vagina obstruction ±èÁÖ¿¬(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:30~09:40 (±¸¿¬¹ßÇ¥)Hormone replacement therapy and Breast cancer incidence in Korean women. ½É¿¹ºó(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:40~09:50 (±¸¿¬¹ßÇ¥)Relationship between handgrip strength and metabolic syndrome in Korean postmenopausal women: the Korea National Health and Nutrition Examination Survey ÀÌÀºÁø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:50~10:00 (±¸¿¬¹ßÇ¥)A study of digital therapeutics for menopausal women with sarcopenia Á¤¿¬¼ö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 10:00~10:10 (±¸¿¬¹ßÇ¥)The association between tamoxifen use and menopause-related symptoms among women with breast cancer ÃÖº°ÀÌ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 10:10~10:20 (±¸¿¬¹ßÇ¥)Æó°æ±â È£¸£¸ó Ä¡·áÁ¦¿Í ¾ÏÀÇ ¿¬°ü¼º: Çѱ¹ÀÇ Àü±¹ÀûÀÎ ÈÄÇâÀû ÄÚȣƮ ¿¬±¸ À°Áø¼º(ÀÎÁ¦ÀÇ´ë)
ÈÞ½Ä 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 10:20~10:40 Coffee Break ( )
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 10:40~11:10 menopause Management : Update for 2023 Jan L. Shifren(ÇØ¿Ü¿¬ÀÚ)
Åä·Ð 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 11:10~11:20 Q&A ( )
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 11:20~11:40 ´º·ÎÅ°´Ñ ¼ö¿ëü ÀÛ¿ë±âÀü°ú Fezolinentant, Elizanetant ¿¬±¸ °á°ú Á¤¸® ¹ÚÇöÅÂ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 11:40~12:00 Genitourinary syndrome of menopauseÀÇ ¾à¹° Ä¡·á ¹Ú¼Ò¿¬(ÀÌÈÀÇ´ë)
Åä·Ð 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 12:00~12:10 Q&A ( )
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 12:10~12:30 Treatment journey to protect bones from fractures ³²±ÃÁ¤(°¡Å縯ÀÇ´ë)
½Ä»ç 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 12:30~13:30 Lunch ( )
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 13:30~13:50 °ñ°¨¼ÒÁõ ¾î¶»°Ô Ä¡·áÇÒ±î ±èÀ¯Áø(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 13:50~14:10 °ñ´Ù°øÁõÀÇ Ä¡·á ÈÄ °ñ¹Ðµµ°¡ Áõ°¡µÈ °æ¿ì ¾à¹°Ä¡·á ¼±Åà Àü¼º¿í(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 14:10~14:20 Q&A ( )
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 14:20~14:50 The impacts of MHT on longer-term health consequences of ovarian hormone deficiency À±º´±¸(Re2 Climic)
ÈÞ½Ä 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 14:50~15:10 Coffee Break ³²±ÃÁ¤(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 15:10~15:30 Æó°æ ¿¹ÃøÀ» À§ÇÑ °Ë»ç¹ý ¾÷µ¥ÀÌÆ® Ȳ±Ô¸®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 15:30~15:50 COVID ¹é½Å:¿ù°æ ÀÌ»ó ¹× ³¼Ò ±â´É¿¡ ´ëÇÑ ¿µÇâÀº Á¶½ÃÇö(¿¬¼¼ÀÇ´ë)
Åä·Ð 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 15:50~16:00 Q&A ( )
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 16:00~16:20 È£¸£¸ó Ä¡·á¿Í Ä¡¸Å Á¤À±Áö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 16:20~16:40 À¯¹æ¾Ï ȯÀÚ¿¡¼ Æó°æ Áõ»ó °ü¸®ÀÇ ¾÷µ¥ÀÌÆ® Á¶¹®°æ(Àü³²ÀÇ´ë)
Åä·Ð 11¿ù 19ÀÏ 16:40~16:50 Q&A ( )
±âŸ 11¿ù 19ÀÏ 16:50~17:00 ½Ã»ó ( )
±âŸ 11¿ù 19ÀÏ 17:00~17:05 Æóȸ ( )